Post‐market safety warnings for drugs approved in Canada under the Notice of Compliance with conditions policy

E-ISSN： 1365-2125|79|5|847-859

ISSN： 0306-5251

Source： BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.79, Iss.5, 2015-05, pp. : 847-859

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulatory review time and post‐market safety events for novel medicines approved by the EMA between 2001 and 2010: a cross‐sectional study

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 306-5251, Iss. 4, 2015-10 ,pp. : 716-726

John Wiley & Sons Inc

Access to resources Recommend Favorite

Regulatory review time and post‐market safety events for novel medicines approved by the EMA between 2001 and 2010: a cross‐sectional study

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 4, 2015-10 ,pp. : 716-726

John Wiley & Sons Inc

Access to resources Recommend Favorite

Post-market surveillance to detect adverse events associated with Melody^® valve implantation

Cardiology in the Young, Vol. 27, Iss. 6, 2016-11 ,pp. : 1090-1097

Cambridge University Press

Access to resources Recommend Favorite

Outcome after one year of upper airway stimulation for obstructive sleep apnea in a multicenter German post‐market study

THE LARYNGOSCOPE, Vol. 128, Iss. 2, 2018-02 ,pp. : 509-515

John Wiley & Sons Inc

Access to resources Recommend Favorite

Approved: Revisions to the Public Information Policy

JCAH Perspectives, Vol. 29, Iss. 4, 2009-04 ,pp. : 3-3

Joint Commission Resources

Access to resources Recommend Favorite